These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 577860)

  • 1. [Model building in pharmacokinetics/Part V: Simulation of blood level curves following repetitive dosing and their experimental verification (author's transl)].
    Hammer R; Bozler G; Heinzel G; Koss FW
    Arzneimittelforschung; 1977; 27(4a):928-31. PubMed ID: 577860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Model building in pharmacokinetics/Part I: General strategy (author's transl)].
    Bozler G; Heinzel G; Koss FW; Wolf M
    Arzneimittelforschung; 1977; 27(4a):897-900. PubMed ID: 577856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple electronic circuit for simulation of pharmacokinetic processes.
    Danek A; Poczatek J
    Arzneimittelforschung; 1976; 26(3):321-4. PubMed ID: 989320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Model building in pharmacokinetics/Part IV: Derivation of microconstants in linear compartment models (author's transl)].
    Heinzel G; WOLF M; Hammer R; Koss FW; Bozler G
    Arzneimittelforschung; 1977; 27(4a):912-28. PubMed ID: 577859
    [No Abstract]   [Full Text] [Related]  

  • 5. [Model building in pharmacokinetics/Part III: Simplified rules for the deduction of analytical solutions for linear compartment models (author's transl)].
    Heinzel G; Hammer R; Wolf M; Koss FW; Bozler G
    Arzneimittelforschung; 1977; 27(4a):904-11. PubMed ID: 577858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Model building in pharmacokinetics/Part II: Generalized theoretical presentation of complete integration of linear compartment models of optional structure (author's transl)].
    Wolf M; Heinzel G; Koss FW; Bozler G
    Arzneimittelforschung; 1977; 27(4a):900-4. PubMed ID: 577857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Method for controlled establishment of steady-state plasma levels through multiple dosing.
    Weiss M; Förster W
    Int J Clin Pharmacol Biopharm; 1978 Mar; 16(3):102-4. PubMed ID: 649225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of simulation to develop multiple-dose regimens for drugs exhibiting nonlinear elimination kinetics.
    Hepler CD; Prince RA
    Am J Hosp Pharm; 1980 Dec; 37(12):1631-5. PubMed ID: 7446538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of amixetrine in the dog. Relation of dose-to-plasma concentration.
    Constantin M; Pognat JF
    Arzneimittelforschung; 1978; 28(4):646-51. PubMed ID: 581941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactive simulator for pharmacokinetics of repetitive drug dosing.
    Iben GA; Anderson JH
    Comput Programs Biomed; 1975 Mar; 4(3):113-20. PubMed ID: 1139911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confounding factors for sex differences in pharmacokinetics and pharmacodynamics: focus on dosing regimen, dosage form, and formulation.
    Chen ML
    Clin Pharmacol Ther; 2005 Oct; 78(4):322-9. PubMed ID: 16198651
    [No Abstract]   [Full Text] [Related]  

  • 12. [Computer simulation of blood level profiles. Drug liberation from two sustained-release preparations and computer simulation of single- and multiple-dose pharmacokinetics].
    Koch HP
    Pharmazie; 1992 Jul; 47(7):547-52. PubMed ID: 1518902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose size and dosing interval determination.
    Ritschel WA
    Arzneimittelforschung; 1975 Sep; 25(9):1442-7. PubMed ID: 1242670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative relationships between dynamics and kinetics of drugs: a systems dynamics approach.
    van Rossum JM; Burgers JP
    Drug Metab Rev; 1984; 15(1-2):365-82. PubMed ID: 6378560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PK-PD integration and PK-PD modelling of nonsteroidal anti-inflammatory drugs: principles and applications in veterinary pharmacology.
    Lees P; Giraudel J; Landoni MF; Toutain PL
    J Vet Pharmacol Ther; 2004 Dec; 27(6):491-502. PubMed ID: 15601443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic comparison of the one-point method with other methods in predicting steady state drug concentrations in multiple dosing.
    Ritschel WA; Erni W
    Int J Clin Pharmacol Biopharm; 1977 Jun; 15(6):279-87. PubMed ID: 881281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a programmable hand-held calculator for clinical pharmacokinetics.
    Foster TS; Bourne DW
    Am J Hosp Pharm; 1977 Jan; 34(1):70-5. PubMed ID: 831476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of multiple-dose blood level curves of drugs with rapid changes in doses and/or dosing intervals.
    Ng PK; Collins-Nakai RL
    Int J Biomed Comput; 1983 Jul; 14(4):275-86. PubMed ID: 6688606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of computers in pharmacokinetics.
    Danek A
    Int J Clin Pharmacol Biopharm; 1978 Aug; 16(8):345-50. PubMed ID: 689793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reanalysis of carbamazepine and carbamazepine-epoxide pharmacokinetics after multiple dosing of extended release formulation.
    Konsil J; Dechasathian S; Mason DH; Stevens RE
    J Pharm Pharm Sci; 2002; 5(2):169-75. PubMed ID: 12207869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.